Yubo International Biotech Limited
YBGJ · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $9 | $6 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $9 | $6 | $5 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 72.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 1,725,672.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 1,609,188.9% |
| EPS Diluted | -0.002 | -0.002 | -0.004 | -0.002 |
| % Growth | 0% | 47.2% | -50% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$1 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$1 |